MEDIWELCOME HEALTHCARE MANAGEMENT & TECHNOLOGY INC. Mediwelcome Healthcare Management & Technology Inc. Stock
Equities
2159
KYG5960A1076
Business Support Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.415 HKD | +1.22% |
|
+3.75% | -18.63% |
| Sales 2021 | 708M 97.76M 765M 134M | Sales 2022 | 323M 44.63M 349M 61.01M | Capitalization | 244M 33.64M 263M 45.99M |
|---|---|---|---|---|---|
| Net income 2021 | 4M 552K 4.32M 755K | Net income 2022 | -89M -12.28M -96.15M -16.79M | EV / Sales 2021 | 0.09 x |
| Net cash position 2021 | 150M 20.65M 162M 28.23M | Net cash position 2022 | 128M 17.6M 138M 24.06M | EV / Sales 2022 | 0.36 x |
| P/E ratio 2021 |
42.5
x | P/E ratio 2022 |
-2.54
x | Employees | 335 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.24% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.22% | ||
| 1 week | +3.75% | ||
| Current month | -17.00% | ||
| 1 month | -14.43% | ||
| 3 months | -14.43% | ||
| 6 months | -34.13% | ||
| Current year | -18.63% |
1 week
0.40
0.42
1 month
0.400.50
Current year
0.360.61
1 year
0.361.15
3 years
0.362.74
5 years
0.364.81
10 years
0.364.81
| Managers | Title | Age | Since |
|---|---|---|---|
Liang Wang
FOU | Founder | 49 | 00-08-31 |
Gui Jin Liu
DFI | Director of Finance/CFO | 44 | 03-11-30 |
Hai Dong Jiang
CTO | Chief Tech/Sci/R&D Officer | 49 | 19-08-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Rui Lin Song
BRD | Director/Board Member | 61 | 20-04-30 |
Liang Wang
FOU | Founder | 49 | 00-08-31 |
Wei Min Yang
FOU | Founder | 58 | 00-08-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 0.415 | +1.22% | 0 |
| 24-04-25 | 0.41 | 0.00% | 2,400 |
| 24-04-24 | 0.41 | +2.50% | 0 |
| 24-04-23 | 0.4 | 0.00% | 0 |
| 24-04-22 | 0.4 | 0.00% | 29,600 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 04:08 am
More quotes
Mediwelcome Healthcare Management & Technology Inc is a China-based investment holding company that mainly provides comprehensive medical marketing solutions for cardiovascular and cerebrovascular diseases. The Company mainly provides medical conference services, patient education and self-test services, marketing strategy and consulting services, contract research agency services, and Internet hospital services. The Company mainly conducts business within the domestic market.
Sector
Business Support Services
Calendar
2024-08-26
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -18.63% | 10.6M | |
| -2.96% | 739M | |
| -8.22% | 714M | |
| +1.24% | 653M | |
| -1.43% | 604M | |
| -2.01% | 370M | |
| +39.24% | 292M | |
| 0.00% | 260M | |
| +4.55% | 255M | |
| +52.60% | 154M |
- Stock Market
- Equities
- 2159 Stock
